Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AZN
Recent news which mentions AZN
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
3 No-Brainer Stocks to Buy With $500 Right Now
January 31, 2024
Tickers
AZN
GOOG
GOOGL
XOM
Tags
AZN
Market News
XOM
From
Motley Fool
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
Tickers
AZN
BMY
BNTX
CVS
Tags
News
CVS
WBA
From
Benzinga
3 Magnificent Stocks to Buy and Hold Forever
January 27, 2024
Tickers
AZN
REGN
VRTX
Tags
Market News
Recent Press Releases
VRTX
From
Motley Fool
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
Tickers
AZN
BMY
GILD
GRCL
Tags
News
Large Cap
JNJ
From
Benzinga
AstraZeneca Tries To Reach New Ground For Its Lead Cancer Drug Imfinzi With New Data In Liver Cancer Study
January 19, 2024
Tickers
AZN
NEWS
Tags
General
AZN
Market News
From
Benzinga
Check Out What Whales Are Doing With AZN
January 17, 2024
Tickers
AZN
Tags
Benzinga
Options
BZI/UOA
From
Benzinga
Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold
January 15, 2024
Tickers
AZN
GME
LCID
NVAX
Tags
PFE
NASDAQ:NVAX,NASDAQ:LCID,NYSE:GME,NYSE:PFE,NASDAQ:AZN
Stocks to Sell
From
InvestorPlace
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
January 12, 2024
Tickers
AZN
BMY
CYTK
NEWS
Tags
Health Care
Reiteration
Trading Ideas
From
Benzinga
Oxford University Kicks off Human Study for AstraZeneca's COVID-19 Vaccine Technology in Nipah Virus Defense
January 11, 2024
Tickers
AZN
MRNA
NEWS
Tags
Health Care
AI Generated
News
From
Benzinga
Evaluating AstraZeneca Against Peers In Pharmaceuticals Industry
January 09, 2024
Tickers
AZN
NEWS
Tags
Trading Ideas
BZI/IA
Benzinga
From
Benzinga
4 Superior Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
January 06, 2024
Tickers
AZN
BIDU
JD
PLTR
Tags
Recent Press Releases
Market News
PLTR
From
Motley Fool
Strides Toward Lower Drug Costs: Florida Becomes First To Receive Nod To Import Prescription Drugs from Canada
January 05, 2024
Tickers
AZN
BMY
BNTX
CVS
Tags
BNTX
Markets
MRNA
From
Benzinga
With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs
January 05, 2024
Tickers
AZN
GRCL
Tags
AZN
Small Cap
Market News
From
Benzinga
7 Dividend-Paying Stocks To Add To Your Income Portfolio In 2024
January 03, 2024
Tickers
AZN
CVX
DOX
GOLD
Tags
Stocks to Buy
VALE
CVX
From
InvestorPlace
VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today
January 02, 2024
Tickers
AZN
NBIX
NVS
VYGR
Tags
AZN
NBIX
VYGR
From
InvestorPlace
China Approves AstraZeneca-Sanofi's Respiratory Syncytial Virus Drug To Prevent Infection In Infants
January 02, 2024
Tickers
AZN
NEWS
SNY
Tags
Large Cap
Briefs
News
From
Benzinga
2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer
December 29, 2023
Tickers
AZN
MRNA
MYNZ
NEWS
Tags
General
MYNZ
Benzinga
From
Benzinga
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
December 28, 2023
Tickers
AZN
BMY
BNTX
CVS
Tags
GSK
AI Generated
Health Care
From
Benzinga
Why Is Blood Purification Focused CytoSorbents Trading Lower Today?
December 28, 2023
Tickers
AZN
BMY
CTSO
JNJ
Tags
CTSO
Penny Stocks
JNJ
From
Benzinga
Why Is Cytokinetics (CYTK) Stock Up 70% Today?
December 27, 2023
Tickers
AZN
BMY
CYTK
NVS
Tags
NASDAQ:CYTK,NYSE:BMY,NYSE:NVS,NASDAQ:AZN
Today's Market
NVS
From
InvestorPlace
Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned
December 27, 2023
Tickers
AZN
BMY
FUSN
LLY
Tags
Expert Ideas
Upgrades
Movers
From
Benzinga
Investor Sentiment Improves; Dow Jumps Over 150 Points
December 27, 2023
Tickers
AZN
BLIN
GRCL
NEWS
Tags
Small Cap
Benzinga
RYZB
From
Benzinga
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
December 26, 2023
Tickers
AZN
GRCL
ID
IINN
Tags
Trading Ideas
MIST
Penny Stocks
From
Benzinga
Crude Oil Rises Over 3%; US Home Prices Increase In October
December 26, 2023
Tickers
ADEX
AZN
GRCL
IINN
Tags
Trading Ideas
Earnings
Penny Stocks
From
Benzinga
Evaluating AstraZeneca Against Peers In Pharmaceuticals Industry
December 26, 2023
Tickers
AZN
NEWS
Tags
Market News
Markets
AZN
From
Benzinga
Health Care Company AstraZeneca Announces Acquisition of Gracell Biotechnologies
December 26, 2023
Tickers
AZN
GRCL
NEWS
Tags
Trading Ideas
Benzinga
GRCL
From
Benzinga
US Stocks Set To Start Final Trading Week Of Year On Positive Note As Santa Claus Rally Gets Going: Analyst Confident Of Market Finishing Year At Highs
December 26, 2023
Tickers
AZN
GRCL
INTC
LI
Tags
Economics
Louis Navellier
News
From
Benzinga
AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies
December 26, 2023
Tickers
AZN
GRCL
NEWS
Tags
News
Large Cap
Health Care
From
Benzinga
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
December 22, 2023
Tickers
ALNY
AZN
IONS
NEWS
Tags
Analyst Ratings
AZN
Analyst Color
From
Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
December 22, 2023
Tickers
AZN
IONS
NEWS
Tags
News
Large Cap
Trading Ideas
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.